Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.225 USD | +0.41% | -6.49% | +16.67% |
May. 07 | Transcript : Aclaris Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (ACRS) ACLARIS THERAPEUTICS Reports Q1 Revenue $2.4M, vs. Street Est of $2M | MT |
Financials (USD)
Sales 2024 * | 7.96M | Sales 2025 * | 7.39M | Capitalization | 86.94M |
---|---|---|---|---|---|
Net income 2024 * | -58M | Net income 2025 * | -72M | EV / Sales 2024 * | 1.97 x |
Net cash position 2024 * | 71.24M | Net cash position 2025 * | 157M | EV / Sales 2025 * | -9.54 x |
P/E ratio 2024 * |
-1.55
x | P/E ratio 2025 * |
-1.44
x | Employees | 89 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.51% |
Latest transcript on Aclaris Therapeutics, Inc.
1 day | +0.41% | ||
1 week | -6.49% | ||
Current month | +1.24% | ||
1 month | +2.94% | ||
3 months | -0.41% | ||
6 months | -75.10% | ||
Current year | +16.67% |
Managers | Title | Age | Since |
---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 54 | 12-06-30 |
Kevin Balthaser
DFI | Director of Finance/CFO | 37 | 16-12-31 |
Ajay Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Schiff
BRD | Director/Board Member | 58 | 17-08-08 |
Maxine Gowen
BRD | Director/Board Member | 66 | 19-07-01 |
Andrew Powell
BRD | Director/Board Member | 66 | 17-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 1.225 | +0.41% | 124 811 |
24-05-08 | 1.22 | -8.96% | 1,233,870 |
24-05-07 | 1.34 | +2.29% | 736,993 |
24-05-06 | 1.31 | -3.68% | 631,666 |
24-05-03 | 1.36 | +3.82% | 690,119 |
Delayed Quote Nasdaq, May 09, 2024 at 11:55 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.67% | 86.94M | |
+24.97% | 46.71B | |
+48.83% | 41.8B | |
-1.19% | 41.52B | |
-3.42% | 29.55B | |
+10.45% | 25.78B | |
-21.17% | 19.26B | |
+1.22% | 12.14B | |
-3.18% | 12.08B | |
+27.34% | 11.98B |
- Stock Market
- Equities
- ACRS Stock